|
C3ORF21 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.257900E-02 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.437900E-02 |
| Normal-vs-Stage2 |
2.750400E-01 |
| Normal-vs-Stage3 |
3.041400E-01 |
| Normal-vs-Stage4 |
2.930800E-01 |
| Stage1-vs-Stage2 |
7.286600E-01 |
| Stage1-vs-Stage3 |
6.590600E-01 |
| Stage1-vs-Stage4 |
9.386800E-01 |
| Stage2-vs-Stage3 |
9.683800E-01 |
| Stage2-vs-Stage4 |
7.904200E-01 |
| Stage3-vs-Stage4 |
7.794800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.831900E-02 |
| Normal-vs-AfricanAmerican |
5.522100E-02 |
| Normal-vs-Asian |
9.074400E-01 |
| Caucasian-vs-AfricanAmerican |
6.632000E-01 |
| Caucasian-vs-Asian |
4.742000E-01 |
| AfricanAmerican-vs-Asian |
4.014000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
5.360000E-02 |
| Normal-vs-Female |
4.727500E-02 |
| Male-vs-Female |
4.861200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.762000E-01 |
| Normal-vs-Extreme_Weight |
1.349170E-01 |
| Normal-vs-Obese |
5.603800E-02 |
| Normal-vs-Extreme_Obese |
1.569580E-01 |
| Normal_Weight-vs-Extreme_Weight |
1.802050E-01 |
| Normal_Weight-vs-Obese |
6.620100E-02 |
| Normal_Weight-vs-Extreme_Obese |
1.893790E-01 |
| Extreme_Weight-vs-Obese |
4.502000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
4.857200E-01 |
| Obese-vs-Extreme_Obese |
7.754000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.480300E-02 |
| Normal-vs-Age(41-60Yrs) |
4.835400E-03 |
| Normal-vs-Age(61-80Yrs) |
2.252800E-01 |
| Normal-vs-Age(81-100Yrs) |
5.890400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
9.848600E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.364000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.475500E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.113580E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.157880E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.636250E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
3.357400E-04 |
| Normal-VS-Type2 PRCC |
1.047620E-01 |
| Normal-VS-KIRP CIMP |
1.799950E-01 |
| Normal-VS-Unclassified PRCC |
4.415500E-02 |
| Type1 PRCC-VS-Type2 PRCC |
2.09798844963416E-12 |
| Type1 PRCC-VS-KIRP CIMP |
6.115400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
4.209000E-01 |
| Type2 PRCC-VS-KIRP CIMP |
7.394000E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
2.591400E-04 |
| KIRP CIMP-VS-Unclassified PRCC |
9.775000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.146600E-01 |
| Normal-vs-N1 |
6.584400E-01 |
| Normal-vs-N2 |
1.549770E-01 |
| N0-vs-N1 |
6.617000E-01 |
| N0-vs-N2 |
9.100300E-02 |
| N1-vs-N2 |
1.983580E-01 |
|
|
